BioSyent (CVE:RX) Stock Crosses Below 50 Day Moving Average – Time to Sell?

BioSyent Inc. (CVE:RX) shares passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$11.20 and traded as low as C$11.05. BioSyent shares last traded at C$11.10, with a volume of 1,686 shares trading hands.

BioSyent Price Performance

The company has a market cap of C$126.96 million, a PE ratio of 18.01 and a beta of 0.93. The firm’s 50-day moving average is C$11.20 and its 200-day moving average is C$11.00. The company has a quick ratio of 6.91, a current ratio of 3.92 and a debt-to-equity ratio of 2.90.

Insider Transactions at BioSyent

In other BioSyent news, insider FAX Capital Corp. sold 112,400 shares of the firm’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of C$11.28, for a total transaction of C$1,267,557.28. Also, Senior Officer Robert Joseph March sold 4,775 shares of BioSyent stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of C$11.65, for a total transaction of C$55,628.75. In the last quarter, insiders sold 118,344 shares of company stock valued at $1,336,874. Corporate insiders own 33.65% of the company’s stock.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.